共 6 条
A Phase I Study of Panobinostat in Combination With ICE (Ifosfamide, Carboplatin and Etoposide) in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)
被引:0
作者:

不详
论文数: 0 引用数: 0
h-index: 0
机构:
关键词:
D O I:
暂无
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
引用
收藏
页码:5 / 6
页数:2
相关论文
共 6 条
- [1] Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines[J]. BLOOD, 2008, 112 (04) : 1424 - 1433Buglio, Daniela论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USAGeorgakis, Georgios V.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USAHanabuchi, Shino论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USAArima, Kazuhiko论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USAKhaskhely, Noor M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USALiu, Yong-Jun论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USAYounes, Anas论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
- [2] A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model[J]. BLOOD, 2001, 97 (03) : 616 - 623Moskowitz, CH论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USANimer, SD论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAZelenetz, AD论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USATrippett, T论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAHedrick, EE论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAFilippa, D论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USALouie, D论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAGonzales, M论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAWalits, J论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USACoady-Lyons, N论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAQin, J论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAFrank, R论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USABertino, JR论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USACoy, A论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USANoy, A论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAO'Brien, JP论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAStraus, D论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAPortlock, CS论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USAYahalom, J论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
- [3] Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma[J]. BLOOD, 2012, 119 (07) : 1665 - 1670Moskowitz, Craig H.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAMatasar, Matt J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAZelenetz, Andrew D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USANimer, Stephen D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAGerecitano, John论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAHamlin, Paul论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAHorwitz, Steven论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAMoskowitz, Alison J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USANoy, Ariela论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAPalomba, Lia论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAPerales, Miguel-Angel论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAPortlock, Carol论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAStraus, David论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAMaragulia, Jocelyn C.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USASchoder, Heiko论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USAYahalom, Joachim论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Lymphoma Dis Management Team, New York, NY 10065 USA
- [4] A Phase I Study Of Panobinostat In Combination With ICE (Ifosfamide, Carboplatin and Etoposide) In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma (cHL)[J]. BLOOD, 2013, 122 (21)Oki, Yasuhiro论文数: 0 引用数: 0 h-index: 0Fanale, Michelle A.论文数: 0 引用数: 0 h-index: 0Westin, Jason R.论文数: 0 引用数: 0 h-index: 0Fowler, Nathan论文数: 0 引用数: 0 h-index: 0Neelapu, Sattva S.论文数: 0 引用数: 0 h-index: 0Hagemeister, Fredrick B.论文数: 0 引用数: 0 h-index: 0Rodriguez, Maria Alma论文数: 0 引用数: 0 h-index: 0Younes, Anas论文数: 0 引用数: 0 h-index: 0
- [5] A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors[J]. INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 974 - 985Sharma, Sunil论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USA Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USABeck, Joachim论文数: 0 引用数: 0 h-index: 0机构: Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USAMita, Monica论文数: 0 引用数: 0 h-index: 0机构: Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USAPaul, Sofia论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USAWoo, Margaret M.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USASquier, Margaret论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USAGadbaw, Brian论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USAPrince, H. Miles论文数: 0 引用数: 0 h-index: 0机构: Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84103 USA
- [6] Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) : 2197 - 2203Younes, Anas论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USASureda, Anna论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Creu & Sant Pau, Barcelona, Spain Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USABen-Yehuda, Dina论文数: 0 引用数: 0 h-index: 0机构: Hadassah Med Org, Jerusalem, Israel Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAZinzani, Pier Luigi论文数: 0 引用数: 0 h-index: 0机构: Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, Bologna, Italy Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAOng, Tee-Chuan论文数: 0 引用数: 0 h-index: 0机构: Hosp Ampang, Ampang, Selangor, Malaysia Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAPrince, H. Miles论文数: 0 引用数: 0 h-index: 0机构: Univ Melbourne, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAHarrison, Simon J.论文数: 0 引用数: 0 h-index: 0机构: Univ Melbourne, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAKirschbaum, Mark论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, Duarte, CA 91010 USA Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAJohnston, Patrick论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAGallagher, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Florham Pk, NJ USA Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USALe Corre, Christophe论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Florham Pk, NJ USA Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAShen, Angela论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Florham Pk, NJ USA Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USAEngert, Andreas论文数: 0 引用数: 0 h-index: 0机构: Klinikum Univ Koln, Cologne, Germany Univ Texas MD Anderson Canc Ctr, Unite 429, Houston, TX 77030 USA